Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for subacute and chronic refractory cough
IRCT20170215032587N5Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in refractory chronic cough (RCC) comparing Pregabalin with Placebo (2 arms). Primary endpoints: Number of cough attacks per day and Number of coughs per attack. Started Mar 2019; status: completed.
02
Drugs
pregabalin
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on IRCT20170215032587N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170215032587N5.